Research Paper Volume 13, Issue 14 pp 18806—18826

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma

Development of prognostic model based on eight-IRlncRNA signature and clinicopathologic features. (A) Nomogram for predicting the survival probability of 1-, 3-, and 5-year overall survival for PAAD patients. (B) Prediction made by Calibration plot of the nomogram for overall survival.

Figure 5. Development of prognostic model based on eight-IRlncRNA signature and clinicopathologic features. (A) Nomogram for predicting the survival probability of 1-, 3-, and 5-year overall survival for PAAD patients. (B) Prediction made by Calibration plot of the nomogram for overall survival.